Alissa Nolden1, Paule V Joseph2, Kord M Kober3, Bruce A Cooper3, Steven M Paul3, Marilyn J Hammer4, Laura B Dunn5, Yvette P Conley6, Jon D Levine7, Christine Miaskowski8. 1. Food Science Department, College of Natural Sciences, University of Massachusetts, Amherst, Massachusetts, USA. 2. Sensory Science & Metabolism Unit, Biobehavioral Branch, Division of Intramural Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA. 3. Department of Physiological Nursing, School of Nursing, University of California San Francisco, San Francisco, California, USA. 4. Department of Nursing, Mount Sinai Medical Center, New York, New York, USA. 5. School of Medicine, Stanford University, Stanford, California, USA. 6. School of Nursing, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 7. School of Medicine, University of California, San Francisco, California, USA. 8. Department of Physiological Nursing, School of Nursing, University of California San Francisco, San Francisco, California, USA. Electronic address: chris.miaskowski@ucsf.edu.
Abstract
CONTEXT: Over 80% of patients with cancer report taste changes. Despite the high prevalence of this symptom and its negative effects on health, few studies have assessed its association with other gastrointestinal (GI) symptoms. OBJECTIVES: Determine the occurrence, frequency, severity, and distress of patient-reported "change in the way food tastes" (CFT) and identify phenotypic and GI symptoms characteristics associated with its occurrence. METHODS: Patients receiving chemotherapy for breast, GI, gynecological, or lung cancer completed demographic and symptom questionnaires prior to their second or third cycle of chemotherapy. CFT was assessed using the Memorial Symptom Assessment Scale. Differences in demographic, clinical, and GI symptom characteristics were evaluated using parametric and nonparametric tests. RESULTS: Of the 1329 patients, 49.4% reported experiencing CFT in the week prior to their second or third cycle of chemotherapy. In the univariate analysis, patients who reported CFT had fewer years of education; were more likely to be black or Hispanic, mixed race, or other; and had a lower annual household income. A higher percentage of patients with CFT reported the occurrence of 13 GI symptoms (e.g., constipation, diarrhea, abdominal cramps, feeling bloated). In a multivariable logistic regression analysis, compared with patients with breast cancer, patients with lung cancer (odds ratio = 0.55; P = 0.004) had a decrease in the odds of being in the CFT group. Patients who received a neurokinin-1 receptor antagonist and two other antiemetics were at an increased odds of being in the CFT group (odds ratio = 2.51; P = 0.001). Eight of the 13 GI symptoms evaluated were associated with an increased odds of being in the CFT group. CONCLUSIONS: This study provides new evidence on the frequency, severity, and distress of CFT in oncology patients undergoing chemotherapy. These findings suggest that CFT is an important problem that warrants ongoing assessments and nutritional interventions.
CONTEXT: Over 80% of patients with cancer report taste changes. Despite the high prevalence of this symptom and its negative effects on health, few studies have assessed its association with other gastrointestinal (GI) symptoms. OBJECTIVES: Determine the occurrence, frequency, severity, and distress of patient-reported "change in the way food tastes" (CFT) and identify phenotypic and GI symptoms characteristics associated with its occurrence. METHODS:Patients receiving chemotherapy for breast, GI, gynecological, or lung cancer completed demographic and symptom questionnaires prior to their second or third cycle of chemotherapy. CFT was assessed using the Memorial Symptom Assessment Scale. Differences in demographic, clinical, and GI symptom characteristics were evaluated using parametric and nonparametric tests. RESULTS: Of the 1329 patients, 49.4% reported experiencing CFT in the week prior to their second or third cycle of chemotherapy. In the univariate analysis, patients who reported CFT had fewer years of education; were more likely to be black or Hispanic, mixed race, or other; and had a lower annual household income. A higher percentage of patients with CFT reported the occurrence of 13 GI symptoms (e.g., constipation, diarrhea, abdominal cramps, feeling bloated). In a multivariable logistic regression analysis, compared with patients with breast cancer, patients with lung cancer (odds ratio = 0.55; P = 0.004) had a decrease in the odds of being in the CFT group. Patients who received a neurokinin-1 receptor antagonist and two other antiemetics were at an increased odds of being in the CFT group (odds ratio = 2.51; P = 0.001). Eight of the 13 GI symptoms evaluated were associated with an increased odds of being in the CFT group. CONCLUSIONS: This study provides new evidence on the frequency, severity, and distress of CFT in oncology patients undergoing chemotherapy. These findings suggest that CFT is an important problem that warrants ongoing assessments and nutritional interventions.
Authors: Irene IJpma; Remco J Renken; Jourik A Gietema; Riemer H J A Slart; Manon G J Mensink; Joop D Lefrandt; Gert J Ter Horst; Anna K L Reyners Journal: Clin Nutr Date: 2016-10-27 Impact factor: 7.324
Authors: F Roila; A Molassiotis; J Herrstedt; M Aapro; R J Gralla; E Bruera; R A Clark-Snow; L L Dupuis; L H Einhorn; P Feyer; P J Hesketh; K Jordan; I Olver; B L Rapoport; J Roscoe; C H Ruhlmann; D Walsh; D Warr; M van der Wetering Journal: Ann Oncol Date: 2016-09 Impact factor: 32.976
Authors: Catherine Kubrak; Kärin Olson; Naresh Jha; Louise Jensen; Linda McCargar; Hadi Seikaly; Jeffery Harris; Rufus Scrimger; Matthew Parliament; Vickie E Baracos Journal: Head Neck Date: 2010-03 Impact factor: 3.147
Authors: Wendy Wing Tak Lam; Chi Ching Law; Yiu Tung Fu; Kam Hung Wong; Victor T Chang; Richard Fielding Journal: J Pain Symptom Manage Date: 2008-04-22 Impact factor: 3.612
Authors: L E Spotten; C A Corish; C M Lorton; P M Ui Dhuibhir; N C O'Donoghue; B O'Connor; T D Walsh Journal: Ann Oncol Date: 2017-05-01 Impact factor: 32.976
Authors: Paule V Joseph; Alissa Nolden; Kord M Kober; Steven M Paul; Bruce A Cooper; Yvette P Conley; Marilyn J Hammer; Fay Wright; Jon D Levine; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2020-11-28 Impact factor: 5.576